<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23276">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01771913</url>
  </required_header>
  <id_info>
    <org_study_id>boosteredADSCs</org_study_id>
    <nct_id>NCT01771913</nct_id>
  </id_info>
  <brief_title>Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts</brief_title>
  <official_title>Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts for Refinements of Reconstructed Breasts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <authority>Brazil: National Comittee of Ethics in Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate if there is a relationship between the take of
      fat grafts with and without ADSCs and the presence of specific surface markers on the cells
      of the stromal vascular fraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two groups of patients will be studied. The control will receive centrifuged fat grafts
      while the other group will receive centrifuged enriched fat grafts with ADSCs. The
      performance of both grafts will be assessed through volume measurement employing MRI before
      and after 6 months post-op.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Volume maintenance</measure>
    <time_frame>up to 1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>volumetry of the reconstructed breasts will be accomplished through MRI and appropriate software (MRI before and after the interventions)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>immunophenotyping</measure>
    <time_frame>at the day of intervention</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>immunophenotyping of the fresh stromal vascular fraction of both groups</description>
  </secondary_outcome>
  <other_outcome>
    <measure>fat necrosis</measure>
    <time_frame>up to 1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Breast Reconstruction</condition>
  <condition>Contour Irregularities</condition>
  <condition>Volume Insufficiency</condition>
  <arm_group>
    <arm_group_label>centrifuged fat graft</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>female patients who underwent breast reconstruction and present with volume insufficiency will undergo centrifuged fat graft for contour and volume refinements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADSCs enriched centrifuged fat graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>female patients who underwent breast reconstruction and present volume insufficiency will undergo ADSCs enriched fat grafting for volume and irregularity contour improvement</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>centrifuged fat graft</intervention_name>
    <description>fat from the abdominal subcutaneous tissue will be taken by vacuum assisted lipectomy and immediately prepared to be grafted in the reconstructed breast that presents contour irregularities and/or volume insufficiency. No adipose derived stem cells will enrich the fat grafts in this group.</description>
    <arm_group_label>centrifuged fat graft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>ADSCs enriched fat graft</intervention_name>
    <description>fat from the abdominal subcutaneous tissue will be taken by suction assisted lipectomy and stromal vascular fraction will be isolated and immediately added to the fat graft that will be employed to improve contour irregularities and volume insufficiency of reconstructed breasts.</description>
    <arm_group_label>ADSCs enriched centrifuged fat graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  contour irregularities and volume insufficiency in reconstructed breasts no matter
             the method of reconstruction employed

          -  local flaps with conditions to receive fat grafts

          -  good health condition

        Exclusion Criteria:

          -  breast cancer patients under chemotherapy

          -  smokers

          -  bad health condition

          -  patients too thin

          -  patients that require a new reconstructive surgery (secondary reconstruction)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nivaldo Alonso, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luiz Alexandre L Tissiani, MD</last_name>
    <phone>55-11-981798707</phone>
    <email>latissiani@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nivaldo Alonso, PhD</last_name>
    <phone>55-11-981494320</phone>
    <email>nivalonso@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Municipal Carmino Caricchio</name>
      <address>
        <city>Sao Paulo</city>
        <zip>03063-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magali Cortezan, Agendamento</last_name>
      <phone>55-11-33946980</phone>
    </contact>
    <investigator>
      <last_name>Luiz Alexandre L Tissiani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Spear SL, Wilson HB, Lockwood MD. Fat injection to correct contour deformities in the reconstructed breast. Plast Reconstr Surg. 2005 Oct;116(5):1300-5. PubMed PMID: 16217471.</citation>
    <PMID>16217471</PMID>
  </results_reference>
  <results_reference>
    <citation>Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001 Apr;7(2):211-28.</citation>
    <PMID>11304456</PMID>
  </results_reference>
  <results_reference>
    <citation>Gimble JM, Bunnell BA, Casteilla L, Jung JS, Yoshimura K. Phases I-III Clinical Trials Using Adult Stem Cells. Stem Cells Int. 2011 Feb 23;2010:604713. doi: 10.4061/2010/604713.</citation>
    <PMID>21461337</PMID>
  </results_reference>
  <results_reference>
    <citation>Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg. 2008 Jan;32(1):48-55; discussion 56-7. Epub 2007 Sep 1.</citation>
    <PMID>17763894</PMID>
  </results_reference>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 20, 2013</lastchanged_date>
  <firstreceived_date>January 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Luiz Alexandre Lorico Tissiani</investigator_full_name>
    <investigator_title>MD, Chief of Breast Reconstructive Unit at Hospital Municipal Carmino Caricchio</investigator_title>
  </responsible_party>
  <keyword>adipocytes</keyword>
  <keyword>cell transplantations</keyword>
  <keyword>mesenchymal stem cell</keyword>
  <keyword>immunophenotyping</keyword>
  <keyword>adipose tissue</keyword>
  <keyword>breast reconstruction</keyword>
  <keyword>mammaplasty</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>fat necrosis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
